We also did not find a correlation between UCHL1 concentration and the age of the patients, the number of years from the first MS symptoms, the number of years from MS diagnosis, the number of relapses within the 24-month observational period, the EDSS value, the EDSS visual functions, the EDSS brainstem functions, the EDSS pyramidal functions, the EDSS cerebellar functions, the EDSS sensory functions, the EDSS bowel/bladder functions, Cerebral functions, and the Ambulation score (p > 0.05). This evidence concerns the gene UCHL1 and myeloid sarcoma.